PharmaEssentia (6446.TW) Earnings Analysis
PharmaEssentia (6446.TW) next reports earnings on 2026-08-06, consensus EPS 6.22 TWD. Last quarter (2026-03-03) it missed with EPS 3.38 TWD vs 3.67 TWD est (-7.9%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E 71.83.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6446.TW next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 6.22 TWD |
| Revenue estimate | 6.80B |
6446.TW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-03 | 3.38 TWD | 3.67 TWD | -7.9% | Miss |
| 2025-08-12 | 2.45 TWD | 3.41 TWD | -28.2% | Miss |
| 2025-05-09 | 3.06 TWD | 2.87 TWD | +6.6% | Beat |
| 2024-11-14 | 1.99 TWD | 2.06 TWD | -3.4% | Miss |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
6446.TW valuation and analyst view
| Trailing P/E | 71.83 |
|---|---|
| Trailing EPS | 15.976 TWD |
| Price / book | 12.39 |
| Dividend yield | 0.13% |
| Market cap | 486.81B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is PharmaEssentia (6446.TW)'s next earnings date?
PharmaEssentia is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 6.22 TWD and revenue estimate of 6.80B.
Did 6446.TW beat earnings last quarter?
In its 2026-03-03 report, 6446.TW posted EPS of 3.38 TWD versus a 3.67 TWD estimate — a miss of 7.9%.
What is 6446.TW's earnings track record?
Over the last 4 reported quarters with consensus data, 6446.TW beat estimates 1 times (25%).
What is 6446.TW's current P/E ratio and EPS?
6446.TW trades at a trailing P/E of 71.83 on trailing EPS of 15.975750474728294 TWD.
What do analysts rate 6446.TW?
6446.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.